These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17073575)

  • 1. The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.
    Turpeinen M; Raunio H; Pelkonen O
    Curr Drug Metab; 2006 Oct; 7(7):705-14. PubMed ID: 17073575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1',1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2007 Nov; 35(11):2053-9. PubMed ID: 17682072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    Turpeinen M; Nieminen R; Juntunen T; Taavitsainen P; Raunio H; Pelkonen O
    Drug Metab Dispos; 2004 Jun; 32(6):626-31. PubMed ID: 15155554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6.
    Walsky RL; Astuccio AV; Obach RS
    J Clin Pharmacol; 2006 Dec; 46(12):1426-38. PubMed ID: 17101742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.
    Rae JM; Soukhova NV; Flockhart DA; Desta Z
    Drug Metab Dispos; 2002 May; 30(5):525-30. PubMed ID: 11950782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined three-dimensional quantitative structure-activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling.
    Wang Q; Halpert JR
    Drug Metab Dispos; 2002 Jan; 30(1):86-95. PubMed ID: 11744616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
    Richter T; Mürdter TE; Heinkele G; Pleiss J; Tatzel S; Schwab M; Eichelbaum M; Zanger UM
    J Pharmacol Exp Ther; 2004 Jan; 308(1):189-97. PubMed ID: 14563790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC; Wallace AD; Hodgson E; Rose RL
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
    Court MH; Duan SX; Hesse LM; Venkatakrishnan K; Greenblatt DJ
    Anesthesiology; 2001 Jan; 94(1):110-9. PubMed ID: 11135730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms.
    Lee HK; Moon JK; Chang CH; Choi H; Park HW; Park BS; Lee HS; Hwang EC; Lee YD; Liu KH; Kim JH
    Drug Metab Dispos; 2006 Jul; 34(7):1090-5. PubMed ID: 16581944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
    Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
    Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interaction study between bupropion and ticlopidine in male CF-1 mice.
    Molnari JC; Hassan HE; Moeller BM; Myers AL
    Biol Pharm Bull; 2011; 34(3):447-51. PubMed ID: 21372402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion/nifedipine oxidase.
    Hosaka S; Murayama N; Satsukawa M; Shimizu M; Uehara S; Fujino H; Iwasaki K; Iwano S; Uno Y; Yamazaki H
    Drug Metab Dispos; 2015 Jan; 43(1):27-33. PubMed ID: 25318994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
    Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
    Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Model; 2011 Nov; 17(11):2839-46. PubMed ID: 21301907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
    Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.